Fast-growing healthcare technology company Iodine Software has made its second acquisition in less than a month, snapping up its competitor ChartWise Medical Systems.
The company did not disclose the financial terms of the deal.
Austin, Texas-based Iodine Software uses artificial intelligence to solve provider problems such as improving clinical documentation. ChartWise Medical Systems also provides clinical documentation improvement solutions for the healthcare market.
The acquisition expands Iodine’s clinical predictions to more than 800 hospitals and health systems, according to company executives.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
In late May, Iodine Software announced it had acquired mobile-based physician engagement platform Artifact Health, which helps the software company to get its AI technology directly into the hands of more than 80,000 providers across the country.
Iodine Software built a machine learning approach that significantly improves reliability in clinical documentation to help ensure proper reimbursement for health systems. The company experienced rapid growth over the last decade by applying its ML engine to solve midcycle revenue leakage—a problem that costs healthcare systems billions in lost revenue due to resource-intensive, highly manual clinical documentation workflows.
Prior to the ChartWise acquisition, Iodine worked with 550 hospitals and has helped those organizations recognize $1.5 billion in additional appropriate reimbursement annually, according to executives.
The acquisition of ChartWise further signals Iodine’s rapidly advancing strategy to expand its ML technology to serve the broader healthcare market.
“ChartWise has been a top performer in addressing the needs of CDI teams for many years. Not only do they open up access for Iodine to a whole new set of hospitals and health systems, they also bring capabilities and new product innovations that will expand our offerings to the clinical documentation teams we serve,” said William Chan, co-founder, and CEO of Iodine Software, in a statement.
The deal to bring on ChartWise broadens Iodine’s market share, adding hundreds of hospitals across dozens of health systems for a combined reach of more than 800 hospitals across the now combined companies, Chan said.
“ChartWise is particularly well suited to smaller healthcare organizations, whereas the Iodine AwareCDI Suite may not be suitable for the organization’s current stage. ChartWise has also established footholds in several global markets where CDI is just taking root, enabling Iodine to now expand overseas where and when it makes sense,” he told Fierce Healthcare.
Source: Fiercehealthcare